![Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients - ScienceDirect Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1262363607000535-gr1.jpg)
Effects of CB1 antagonist on the control of metabolic functions in obese type 2 diabetic patients - ScienceDirect
![Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders | Arteriosclerosis, Thrombosis, and Vascular Biology Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/3c7236c6-fabc-42dc-b3b6-55817c40bdbd/4ff1.jpeg)
Cannabinoid CB1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders | Arteriosclerosis, Thrombosis, and Vascular Biology
![Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling | eNeuro Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling | eNeuro](https://www.eneuro.org/content/9/6/ENEURO.0276-22.2022/F1.large.jpg)
Coordinated Regulation of CB1 Cannabinoid Receptors and Anandamide Metabolism Stabilizes Network Activity during Homeostatic Downscaling | eNeuro
![Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism - ScienceDirect Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295217306457-fx1.jpg)
Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism - ScienceDirect
![Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy | Beni-Suef University Journal of Basic and Applied Sciences | Full Text Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy | Beni-Suef University Journal of Basic and Applied Sciences | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs43088-021-00121-y/MediaObjects/43088_2021_121_Figa_HTML.png)
Role of endocannabinoid CB1 receptors in Streptozotocin-induced uninephrectomised Wistar rats in diabetic nephropathy | Beni-Suef University Journal of Basic and Applied Sciences | Full Text
![Inversago Pharma startet klinische Studien und beginnt mit einer Phase-1-Studie mit INV-101, dem führenden peripheren CB1-Blocker des Unternehmens | Business Wire Inversago Pharma startet klinische Studien und beginnt mit einer Phase-1-Studie mit INV-101, dem führenden peripheren CB1-Blocker des Unternehmens | Business Wire](https://mms.businesswire.com/media/20200929005803/de/825794/22/Inversago_RGB.jpg)
Inversago Pharma startet klinische Studien und beginnt mit einer Phase-1-Studie mit INV-101, dem führenden peripheren CB1-Blocker des Unternehmens | Business Wire
![Personalized medicine can pave the way for the safe use of CB1 receptor antagonists: Trends in Pharmacological Sciences Personalized medicine can pave the way for the safe use of CB1 receptor antagonists: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/f0640a45-b285-41e8-bf40-fb80e3b87eec/gr1.jpg)
Personalized medicine can pave the way for the safe use of CB1 receptor antagonists: Trends in Pharmacological Sciences
![Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge](https://pub.mdpi-res.com/cells/cells-11-03262/article_deploy/html/images/cells-11-03262-g005.png?1666078228)
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
![Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge](https://www.mdpi.com/cells/cells-11-03262/article_deploy/html/images/cells-11-03262-g002.png)
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
![Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge](https://pub.mdpi-res.com/cells/cells-11-03262/article_deploy/html/images/cells-11-03262-g004.png?1666078230)
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB1R) Antagonist | ACS Pharmacology & Translational Science
![Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice | International Journal of Obesity Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice | International Journal of Obesity](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41366-020-0577-8/MediaObjects/41366_2020_577_Fig1_HTML.png)
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice | International Journal of Obesity
![A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders: Trends in Pharmacological Sciences A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/6996453c-ef42-4798-be9a-59f9cd0edc90/gr1.jpg)
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders: Trends in Pharmacological Sciences
![Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge](https://www.mdpi.com/cells/cells-11-03262/article_deploy/html/images/cells-11-03262-g001.png)